In some embodiments, systems and methods can include a wearable device with an electrically conductive skin interface that excites the underlying nerves from a transcutaneous surface stimulator. The device may be sized for a range of user sizes with stimulation electrodes positioned to target the appropriate nerves, such as the saphenous and/or posterior tibial nerves. The therapy may be adjusted based on leg restlessness or movement.

In some embodiments, systems and methods can include a wearable device with an electrically conductive skin interface that excites the underlying nerves from a transcutaneous surface stimulator. The device may be sized for a range of user sizes with stimulation electrodes positioned to target the appropriate nerves, such as the peroneal, femoral, saphenous and/or tibial nerves. The stimulation may include burst stimulation, and involve receiving an input relating to autonomic nervous system activity of the patient.

The present disclosure belongs to the field of treatment devices, and specifically relates to a medicated thread drainage treatment device. The treatment device includes a first treatment unit used for postoperative pain relief and drainage; a second treatment unit used for promoting quick healing of a wound; a third treatment unit used for preventing deep venous thrombosis; and an electropneumatic, negative-pressure, electric stimulation multipurpose therapy apparatus connected with the first treatment unit, the second treatment unit, and the third treatment unit and providing electropneumatic pressure, negative pressure, and electric energy. The present disclosure is used for postoperative quick healing and recovery; promotion of clinical use guidelines will greatly reduce and even eliminate the postoperative complications, particularly postoperative complications of pulmonary embolism, thus saving patients' lives.

Tumors in portions of a subject's body that have a longitudinal axis (e.g., the torso, head, and arm) can be treated with TTFields by affixing first and second sets of electrodes at respective positions that are longitudinally prior to and subsequent to a target region. An AC voltage with a frequency of 100-500 kHz is applied between these sets of electrodes. This imposes an AC electric field with field lines that run through the target region longitudinally. The field strength is at least 1 V/cm in at least a portion of the target region. In some embodiments, this approach is combined with the application of AC electric fields through the target region in a lateral direction (e.g., front to back and/or side to side) in order to apply AC electric fields with different orientations to the target region.

An electrical stimulation device is provided. According to one embodiment of the present invention, the electrical stimulation device for applying an electrical stimulation to the skin of a user comprises: a patch layer, which is a single patch layer and makes contact with the skin of the user when the electrical stimulation device is worn by or attached to the user; and a plurality of patch segments formed to be spaced apart from each other on the patch layer and transmitting current to the patch layer.

Portable transdermal electrical stimulation (TES) applicators for modifying a subject's cognitive state by applying stimulation to the subject's skin. One or more electrode may be on the subject's mastoid, and/or on or near the back of the subject's neck. The portable applicators are configured and adapted to be lightweight and may be wearable, and to deliver a high-intensity TES able to evoke or enhance a predetermined cognitive effect to stimulate either the trigeminal, facial and/or cervical plexus. These TES applicators may include a pair of electrodes and a TES control module comprising a processor, a timer and a waveform generator.

An electrostimulation apparatus may comprise a control unit, a power supply and a carrier separated or combined. The control unit is configured to provide the electrical current to an electrode layer settled on or inside the carrier, and the power supply is configured to heat a heating piece settled on or inside the carrier. The carrier has a plurality of connecting portions which are configured to electrically connect to the control unit, the power supply, the heating piece and the electrode layer. Furthermore, the electrode layer is electrically connected to the control unit through the connecting portions, and also the heating piece is electrically connected to the power supply through the connecting portions. Also, the heating piece and the electrode layer are attached on the carrier, and the carrier can be used to serve both training and treatment purposes for a user.

A wearable medical device comprising: a plurality of patient interface components each configured to interface with a patient; a first patient interface component of the plurality of patient interface components, the first patient interface component comprising a first sensing electrode for receiving one or more signals from a first patient, and a first therapy electrode for delivering a first treatment to the first patient; a second patient interface component of the plurality of patient interface components, the second patient interface component comprising a second sensing electrode for receiving one or more signals from a second patient; and one or more processors in communication with the plurality of patient interface components, the one or more processors configured to detect a first condition of the first patient based at least in part on the one or more signals from the first patient, cause the first treatment to be delivered to the first patient, wherein the first treatment is based at least in part on the detected first condition of the first patient, and detect a second condition of the second patient based at least in part on the one or more signals from the second patient.

A method and system for creating shear stress and endothelial mechanotransduction through neuromuscular stimulation of the muscle pump. Chronic application a minimum of 30 days triggers the autocrine and paracrine processes which elevates production of vasoactive substances including nitric oxide, prostacyclin, superoxide dismutase, thrombomodulin, glutathion, Krupple-like factor 2 and many others. Chronic application also promotes angiogenesis and development of collateral circulation. This is a cost-effective, non-invasive, drug-free therapy to treat vascular dysfunction and ameliorate or reverse its effects on cardiovascular health.

An adherent device to monitor a patient for an extended period comprises a breathable tape. The breathable tape comprises a porous material with an adhesive coating to adhere the breathable tape to a skin of the patient. At least one electrode is affixed to the breathable tape and capable of electrically coupling to a skin of the patient. A printed circuit board is connected to the breathable tape to support the printed circuit board with the breathable tape when the tape is adhered to the patient. Electronic components electrically are connected to the printed circuit board and coupled to the at least one electrode to measure physiologic signals of the patient. A breathable cover and/or an electronics housing is disposed over the circuit board and electronic components and connected to at least one of the electronics components, the printed circuit board or the breathable tape.